Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country

<div><p>Jordan was the first Arab country to enact clinical research regulations. The country has a well-flourished pharmaceutical industry that leans heavily on clinical research (CR) for drug development and post-marketing surveillance. In this cross-sectional study, we sought to asses...

Full description

Saved in:
Bibliographic Details
Main Author: Kamal M. Al-Shami (12936653) (author)
Other Authors: Wesam S. Ahmed (10170053) (author), Karem H. Alzoubi (8744904) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513526479978496
author Kamal M. Al-Shami (12936653)
author2 Wesam S. Ahmed (10170053)
Karem H. Alzoubi (8744904)
author2_role author
author
author_facet Kamal M. Al-Shami (12936653)
Wesam S. Ahmed (10170053)
Karem H. Alzoubi (8744904)
author_role author
dc.creator.none.fl_str_mv Kamal M. Al-Shami (12936653)
Wesam S. Ahmed (10170053)
Karem H. Alzoubi (8744904)
dc.date.none.fl_str_mv 2022-06-24T03:00:00Z
dc.identifier.none.fl_str_mv 10.1371/journal.pone.0270300
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Motivators_and_barriers_towards_clinical_research_participation_A_population-based_survey_from_an_Arab_MENA_country/25257235
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Health sciences
Public health
Clinical Research
Public Health Research
Middle East and North Africa (MENA) Region
Pharmaceutical Industry
Drug Development
Post-marketing Surveillance
Population-based Study
Altruism
Ethics and Regulatory Review
Confidentiality
Refugee Population
Demographic Characteristics
Misconceptions
Research Ethics
Generalizability
dc.title.none.fl_str_mv Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <div><p>Jordan was the first Arab country to enact clinical research regulations. The country has a well-flourished pharmaceutical industry that leans heavily on clinical research (CR) for drug development and post-marketing surveillance. In this cross-sectional study, we sought to assess the public’s awareness and attitude towards CR as well as their perceived motivators and barriers to CR participation. A population-based, self-administered questionnaire was distributed to the general public in Jordan. Among the 1061 participants in this survey, 74% reported being aware of CR. The majority (70%) agreed to the role of CR in health promotion. Online information and healthcare staff were the two main sources of CR information for the participants. About 25% of the participants received prior invitations to participate in CR with 21% agreeing to participate. However, most participants of the current study (63%) were willing to participate in future CR. Contributing to science, benefiting others, and promoting one’s own health were the top motivating factors for participating in CR; while time constraints, fear of research procedure, and lack of interest were the most cited reasons for rejecting participation. Filling out questionnaire surveys, donating blood samples, and participating in physical examinations were the main CR contributions of the participants. Nearly 31% of the participants believed that CR is conducted in a responsible and ethical manner, while 57% did not have an opinion regarding the same matter. In addition, 49% and 44% were neutral with regards to the degree of harm and confidentiality posed by CR. While only 27% disagreed that CR exposes participants to some form of harm, 48% either strongly agreed (15%) or agreed (33%) that it maintains high level of confidentiality for participants. The current study provides insight into the public’s perception of CR in Jordan as well as its motivating factors and perceived barriers towards participating in CR. We envisage to utilize this insight as an aid in the design of vigilant future awareness campaigns and recruitment strategies.</p><p> </p></div><h2>Other Information</h2> <p> Published in: PLOS ONE<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1371/journal.pone.0270300" target="_blank">https://dx.doi.org/10.1371/journal.pone.0270300</a></p>
eu_rights_str_mv openAccess
id Manara2_3ed0388d3ab164cc05b9c9e79c518cec
identifier_str_mv 10.1371/journal.pone.0270300
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25257235
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA countryKamal M. Al-Shami (12936653)Wesam S. Ahmed (10170053)Karem H. Alzoubi (8744904)Biomedical and clinical sciencesClinical sciencesHealth sciencesPublic healthClinical ResearchPublic Health ResearchMiddle East and North Africa (MENA) RegionPharmaceutical IndustryDrug DevelopmentPost-marketing SurveillancePopulation-based StudyAltruismEthics and Regulatory ReviewConfidentialityRefugee PopulationDemographic CharacteristicsMisconceptionsResearch EthicsGeneralizability<div><p>Jordan was the first Arab country to enact clinical research regulations. The country has a well-flourished pharmaceutical industry that leans heavily on clinical research (CR) for drug development and post-marketing surveillance. In this cross-sectional study, we sought to assess the public’s awareness and attitude towards CR as well as their perceived motivators and barriers to CR participation. A population-based, self-administered questionnaire was distributed to the general public in Jordan. Among the 1061 participants in this survey, 74% reported being aware of CR. The majority (70%) agreed to the role of CR in health promotion. Online information and healthcare staff were the two main sources of CR information for the participants. About 25% of the participants received prior invitations to participate in CR with 21% agreeing to participate. However, most participants of the current study (63%) were willing to participate in future CR. Contributing to science, benefiting others, and promoting one’s own health were the top motivating factors for participating in CR; while time constraints, fear of research procedure, and lack of interest were the most cited reasons for rejecting participation. Filling out questionnaire surveys, donating blood samples, and participating in physical examinations were the main CR contributions of the participants. Nearly 31% of the participants believed that CR is conducted in a responsible and ethical manner, while 57% did not have an opinion regarding the same matter. In addition, 49% and 44% were neutral with regards to the degree of harm and confidentiality posed by CR. While only 27% disagreed that CR exposes participants to some form of harm, 48% either strongly agreed (15%) or agreed (33%) that it maintains high level of confidentiality for participants. The current study provides insight into the public’s perception of CR in Jordan as well as its motivating factors and perceived barriers towards participating in CR. We envisage to utilize this insight as an aid in the design of vigilant future awareness campaigns and recruitment strategies.</p><p> </p></div><h2>Other Information</h2> <p> Published in: PLOS ONE<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1371/journal.pone.0270300" target="_blank">https://dx.doi.org/10.1371/journal.pone.0270300</a></p>2022-06-24T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1371/journal.pone.0270300https://figshare.com/articles/journal_contribution/Motivators_and_barriers_towards_clinical_research_participation_A_population-based_survey_from_an_Arab_MENA_country/25257235CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/252572352022-06-24T03:00:00Z
spellingShingle Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
Kamal M. Al-Shami (12936653)
Biomedical and clinical sciences
Clinical sciences
Health sciences
Public health
Clinical Research
Public Health Research
Middle East and North Africa (MENA) Region
Pharmaceutical Industry
Drug Development
Post-marketing Surveillance
Population-based Study
Altruism
Ethics and Regulatory Review
Confidentiality
Refugee Population
Demographic Characteristics
Misconceptions
Research Ethics
Generalizability
status_str publishedVersion
title Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
title_full Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
title_fullStr Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
title_full_unstemmed Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
title_short Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
title_sort Motivators and barriers towards clinical research participation: A population-based survey from an Arab MENA country
topic Biomedical and clinical sciences
Clinical sciences
Health sciences
Public health
Clinical Research
Public Health Research
Middle East and North Africa (MENA) Region
Pharmaceutical Industry
Drug Development
Post-marketing Surveillance
Population-based Study
Altruism
Ethics and Regulatory Review
Confidentiality
Refugee Population
Demographic Characteristics
Misconceptions
Research Ethics
Generalizability